Some common types include aneroid, mercury, and digital sphygmomanometers. Precise blood pressure measurement helps diagnose and manage conditions like hypertension, which has become more prevalent due to sedentary lifestyle and poor diet. The increasing awareness about health and management of lifestyle diseases is driving the demand for sphygmomanometers globally.

The Global Sphygmomanometer Market is estimated to be valued at US$ 3.92 Bn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Sphygmomanometer market are Omron Healthcare, ICU Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, AD Medical, Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International Ltd., PAUL HARTMANN, BPL Medical Technologies, and Homedics.

Key opportunities in the market include development of Bluetooth and Wi-Fi enabled smart sphygmomanometers for remote monitoring. Furthermore, growing telemedicine sector is expected to drive demand for home-use blood pressure monitors.

Technological advancements like incorporation of artificial intelligence and integration of sphygmomanometers with EMR systems are boosting the market growth. Developments in oscillometric technique for improved accuracy compared to auscultatory method is another key advancement.

Market Drivers
Increasing prevalence of lifestyle diseases like hypertension, cardiovascular diseases, and diabetes globally due to sedentary jobs, junk food consumption, and lack of exercise is a major driver for the sphygmomanometer market. Growing geriatric population, who are at higher risk of chronic conditions, further boosts the demand. Favorable government policies for preventive healthcare and reimbursement for blood pressure monitoring devices is another factor fueling the market growth.

Current challenges in the Sphygmomanometer Market:
The Sphygmomanometer Market Size  is facing few challenges which are hindering its growth. One of the major challenge is lack of awareness about the latest advancements in blood pressure monitoring devices in developing regions. High cost of advanced automated blood pressure monitors is another challenge as it makes them inaccessible for people in low income countries. Inaccurate readings from low quality and inexpensive devices also raise questions on reliability of devices which is negatively impacting their adoption. Lack of proper calibration of devices during usage is another area of concern.

SWOT Analysis
Strength: Automated blood pressure monitors provide faster, consistent and accurate readings; Growing elderly population prone to hypertension is driving their demand.
Weakness: Higher cost of automated devices restricts their usage; Traditional mercury sphygmomanometers are difficult to use.
Opportunity: Expanding healthcare infrastructure and growing disease awareness in developing world; Integration of smart connectivity in devices.
Threats: Safety issues with mercury devices can affect their sales; Preference for home monitoring devices threatens sales of hospital devices.

Get more insights on - Sphygmomanometer Market